Therefore, early intestinal dysbiosis could contribute to the progression of NAFLD by modifying bile acids and their derivatives and by regulating the metabolic signaling pathways of FXR and TGR5 involved in NAFLD. Here, GPBAR1 is linked to metabolic dysfunction-associated steatotic liver disease.